Editorial: Therapeutic De-Escalation of Anti-Tumour Necrosis Factor Therapy - Is Less Enough?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Anti-Tumour Necrosis Factor Therapy for Ankylosing Spondylitis: International Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Editorial: Anti-Tumour Necrosis Factor Α Antibodies - Can Efficacy Be Regained?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Review Article: Consensus Statements on Therapeutic Drug Monitoring of Anti-Tumour Necrosis Factor Therapy in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Anti-Cytokine Strategies Beyond Anti-Tumour Necrosis Factor-Α Therapy: Pathophysiology and Clinical Implications

Digestive Diseases
MedicineGastroenterology
2017English

Editorial: Anti-Tumour Necrosis Factor Α Antibodies - Can Efficacy Be Regained? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Tacrolimus vs. Anti-Tumour Necrosis Factor Agents for Moderately to Severely Active Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Pulmonary Granulomas After Tumour Necrosis Factor Alpha Antagonist Therapy

Thorax
PulmonaryRespiratory Medicine
2003English

Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy

Heart
Cardiovascular MedicineCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy